Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iron Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106995372B enables high yield synthesis. Reduces cost and lead time for pharma intermediate manufacturing with scalable green chemistry.
Patent CN106279075B reveals iron-catalyzed HMF conversion to DMF. Achieve cost reduction in renewable chemical intermediates manufacturing with scalable heterogeneous catalysis.
Novel iron catalyst method for Rimegepant intermediates reduces cost and avoids precious metals ensuring supply chain stability and high purity for global pharmaceutical manufacturing partners.
Patent CN115772090A details a green iron-catalyzed amidation for chlorantraniliprole intermediates, offering significant cost reduction in agrochemical manufacturing and enhanced supply chain reliability.
Patent CN110372544A reveals low-cost iron-titanium catalysis for biaryl synthesis. Achieve significant cost reduction and supply chain reliability in pharmaceutical intermediate manufacturing.
Patent CN101654422A reveals a hydrazine-based reduction route for 3,3'-DDS, offering high purity and reduced waste for polymer and epoxy applications.
Patent CN108675942A reveals nanometer vanadium iron catalyst for aromatic nitriles. Mild conditions, high yield, cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103214452B details a novel iron-mediated reduction route for duloxetine intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113666915B reveals a novel 5-step route for posaconazole intermediates using chiral iron catalysis, offering high purity and scalable manufacturing for global supply chains.
Novel Fe-catalyzed alkene oxidation method replaces Pd. High yield up to 98%. Eco-friendly route for pharmaceutical intermediates manufacturing.
Novel FeCl3-catalyzed nitro reduction for Relugolix intermediates eliminates palladium residues, ensuring high purity and cost-effective manufacturing for global supply chains.
Patent CN113651684B reveals a safe, scalable iron-catalyzed oxidation route for 4-hydroxy-2-butynoic acid, offering significant cost reduction in API manufacturing.
Novel photocatalytic route for phosphazene compounds using iron. Mild conditions, high yield, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN114292176B reveals iron-catalyzed synthesis for high-purity diphenyldiquinone. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN119798139A reveals a green iron-catalyzed hydroxylation method. This report analyzes cost reduction and supply chain reliability for high-purity phenolic intermediates.
Patent CN113045479B details a green FeCl3-catalyzed route for 3-hydroxyisoindol-1-ones, offering cost-effective API intermediate manufacturing solutions.
Patent CN110423185A reveals solvent-free ball milling oxidation. High selectivity, low cost, scalable supply for pharmaceutical intermediates.
Patent CN105732377B reveals high-yield indanone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106995373B reveals a one-pot synthesis method using ammonium iodide. This breakthrough offers significant supply chain stability and cost reduction advantages.
Novel nickel-iron catalytic system enables high-yield dienyl sulfone production. Reduces costs and ensures supply chain stability for global pharmaceutical manufacturers.